Please Wait
Applying Filters...

Drug Approvals by the Medicines Control Council in South Africa containing (alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide. Original Data : South African Medicines Price Registry

Menu
$ API Ref.Price (USD/KG) : 446Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6AbbVie (Pty) Ltd

02 2Cipla Medpro (Pty) Ltd

03 2Mylan (Pty) Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Kaletra Solution

Dosage Form : CAP

Dosage Strength : 133.3mg

Packaging : 180X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie Company Banner

02

arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Kaletra Solution

Dosage Form : SOL

Dosage Strength : 80mg

Packaging : 60X5mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie Company Banner

03

arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Aluvia

Dosage Form : TAB

Dosage Strength : 200mg

Packaging : 120X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie Company Banner

04

arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Aluvia

Dosage Form : TAB

Dosage Strength : 200mg

Packaging : 112X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie Company Banner

05

arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Aluvia 100/25

Dosage Form : TAB

Dosage Strength : 100mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie Company Banner

06

arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Aluvia 100/25

Dosage Form : TAB

Dosage Strength : 100mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie Company Banner

07

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Quadrimune

Dosage Form : CAP

Dosage Strength : 40mg

Packaging : 120X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

08

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Lopimune 40/10 Oral Pellets

Dosage Form : CAP

Dosage Strength : 40mg

Packaging : 120X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

09

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Rilovia 200/50

Dosage Form : FCT

Dosage Strength : 200mg

Packaging : 112X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

10

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Lopinavir

Brand Name : Rilovia 200/50

Dosage Form : FCT

Dosage Strength : 200mg

Packaging : 120X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank